Doctors Recommend These 5 Scans for Early Disease Detection

Lung cancer kills more people worldwide than any other cancer — and the reason is straightforward: it causes no symptoms until it has already spread. A cough that's been there for months. Slightly reduced exercise tolerance. By the time most patients notice something is wrong, the tumour has been growing for years.

An HRCT (High-Resolution CT) chest scan changes this completely. It produces cross-sectional images of the entire lung with extraordinary detail — able to detect a nodule just 2–3mm in size, years before it causes any symptoms. In high-risk populations — current or former smokers, people with occupational dust or chemical exposure, those with a family history of lung cancer, and patients over 50 — annual HRCT lung screening has been shown to reduce lung cancer mortality by over 20%.

Beyond cancer, an HRCT chest is the definitive investigation for post-COVID lung damage — the scarring and fibrosis that can persist for months or years after a COVID-19 infection. If you had a severe COVID illness and still experience breathlessness, fatigue, or reduced exercise capacity, an HRCT chest gives your pulmonologist a clear picture of the state of your lung tissue.

An HRCT chest is also used to detect pulmonary fibrosis (ILD), bronchiectasis, emphysema, and early tuberculosis changes — all conditions that benefit enormously from early detection before significant lung function has been lost.

Who should get this scan:

• Current smokers aged 40+ or anyone with 20+ pack-year smoking history
• Former smokers who quit within the last 15 years
• People with occupational exposure to asbestos, silica, coal dust, or chemicals
• Patients with persistent cough, unexplained breathlessness, or blood in sputum
• Post-COVID patients with ongoing respiratory symptoms beyond 4–6 weeks
• Anyone with a first-degree relative diagnosed with lung cancer
• Patients on methotrexate, amiodarone, or other pulmonary-toxic medications

More Indians die of heart attacks than any other cause — and Ahmedabad has one of the highest rates of premature cardiovascular disease in the country. The cruel reality is that the first symptom of coronary artery disease for many people is a heart attack. There is no pain, no warning, no chest tightness in the months before it happens. The arteries simply narrow silently — and then one day they block.

A CT Coronary Calcium Score — also called a CAC (Coronary Artery Calcium) scan — measures the amount of calcified plaque in your coronary arteries. Calcified plaque is the visible evidence of atherosclerosis — the process of arterial hardening and narrowing that causes heart attacks and strokes. The result is expressed as an Agatston Score, which places you in a precise cardiovascular risk category.

A calcium score of zero means no detectable calcified plaque — very low risk for a cardiac event in the next 10 years. A score above 400 means significant plaque burden requiring urgent cardiologist review and aggressive risk factor management. Scores between 1 and 400 are graded into low, moderate, and high risk categories, each with clear treatment implications.

This scan has no injection, no contrast, requires no preparation, and takes under 10 minutes. Yet its power to predict and prevent a heart attack is extraordinary. A study published in the Journal of the American Medical Association found that people with a calcium score of 0 had a 10-year cardiovascular event risk of less than 1% — giving both patient and cardiologist genuine reassurance. For those with a high score, the finding triggers statin therapy, aspirin, lifestyle intervention, and sometimes CT angiography for further assessment — decisions that can prevent a fatal event.

Who should get this scan:

• Men aged 45 and above, women aged 55 and above
• Diabetics — even well-controlled diabetes significantly accelerates arterial plaque
• Patients with high cholesterol, especially elevated LDL or Lipoprotein(a)
• Patients with hypertension managed on medication
• Current or past smokers regardless of age
• Anyone with a family history of early heart disease (before 55 in men, 65 in women)
• Patients with borderline risk on standard risk calculators — CAC score resolves the clinical uncertainty

An annual comprehensive ultrasound of the abdomen and pelvis is arguably the most underrated preventive scan available. It costs relatively little, uses zero radiation, is completely painless, and in 20 minutes provides your doctor with a real-time view of virtually every major organ in your abdominal cavity — liver, gallbladder, bile ducts, pancreas, spleen, both kidneys, the aorta, lymph nodes, and the bladder.

The liver is where this scan earns its reputation most decisively. Fatty liver disease (NAFLD) affects an estimated 38% of Indians — making it the most common liver condition in the country. It causes no symptoms for years to decades, progressively advancing from simple fat accumulation to inflammation, fibrosis, cirrhosis, and ultimately liver failure or hepatocellular carcinoma. An annual USG abdomen catches fatty liver at the reversible early stage — when diet, exercise, and medication can stop the progression entirely.

Beyond fatty liver, a USG abdomen detects gallstones (extremely common in Gujarat's population), kidney stones before they cause an acute painful episode, renal cysts, early renal cell carcinoma, splenic abnormalities, lymph node enlargement suggesting lymphoma, and early changes of portal hypertension. For women, the pelvic component adds evaluation of the uterus and ovaries — screening for PCOD, fibroids, and ovarian cysts.

For men over 50, the bladder and prostate are included — assessing post-void residual urine and prostate size, which guides investigation of urinary symptoms and monitoring of BPH (benign prostatic hyperplasia).

Who should get this scan:

• All adults aged 35 and above — annually as part of a routine health check
• Patients with diabetes, obesity, or metabolic syndrome — higher risk of fatty liver and kidney disease
• Anyone with a family history of liver disease, kidney disease, or abdominal cancers
• Patients taking long-term medications that affect liver function (statins, methotrexate, antifungals)
• Heavy alcohol consumers — to screen for early alcoholic liver disease
• Women with irregular periods or pelvic symptoms — add pelvis component for uterus and ovarian screening
• Men over 50 with any urinary symptoms — add bladder and prostate assessment

Every 3 seconds, somewhere in the world, a person suffers an osteoporotic fracture. In India, where Vitamin D deficiency is endemic and calcium-rich dietary practices are inconsistent, this statistic is even more concerning. Hip fractures in elderly Indians carry a one-year mortality rate of 20–30% — comparable to many serious medical diagnoses. And yet the disease that caused that hip fracture — osteoporosis — was invisible for decades beforehand.

A DEXA scan (Dual-Energy X-ray Absorptiometry) measures bone mineral density in the spine and hip with a precision that no other test can match — detecting as little as 1% change in bone density. The result is expressed as a T-score, which your doctor uses to classify your bone health as normal, osteopenic (mildly reduced), or osteoporotic (significantly reduced). Combined with the WHO FRAX tool, the DEXA result also generates a personalised 10-year fracture risk probability — directly guiding treatment decisions.

Early detection of osteopenia or osteoporosis opens a window for highly effective intervention: calcium and Vitamin D supplementation, weight-bearing exercise programmes, bisphosphonate medications, fall prevention strategies, and — in selected cases — newer agents like denosumab or teriparatide. None of these interventions can rebuild bone that has already been lost to a fracture, but all of them can prevent that fracture from happening if osteoporosis is caught early.

The scan itself takes 15 minutes. There is no injection, no enclosed space, no discomfort. You lie on an open padded table fully clothed while the scanner arm passes quietly over your hip and lower spine. Radiation dose is less than a standard chest X-ray.

Who should get this scan:

• All women aged 50 and above (post-menopausal) — baseline DEXA and repeat every 1–2 years
• All men aged 65 and above
• Any adult on long-term corticosteroids (prednisone, prednisolone) for 3+ months
• Patients with rheumatoid arthritis, IBD, thyroid disease, or other conditions affecting bone
• Any adult who has suffered a fragility fracture (broken bone from a minor fall or everyday activity)
• Women who went through early menopause (before age 45)
• Patients on aromatase inhibitors or androgen deprivation therapy for cancer

Breast cancer is the most common cancer affecting Indian women — accounting for 1 in 4 cancer diagnoses. Survival rates for breast cancer caught at Stage 1 are over 90%. Survival rates for cancer caught at Stage 4 drop to below 30%. This stark difference — between survival and non-survival — is determined almost entirely by one factor: how early it was found.

Mammography is a low-dose X-ray specifically designed to image breast tissue. It can detect tumours as small as 5–7mm — years before they become palpable lumps. The test takes 10–15 minutes. Each breast is briefly compressed between two plates while the X-ray image is taken. The compression is uncomfortable for a few seconds but not painful for most women.

Regular mammographic screening has been shown across decades of research to reduce breast cancer mortality by 15–20% in women aged 40–74. The Indian Council of Medical Research and major oncology bodies recommend annual or biennial mammographic screening from age 40 for average-risk women, and from age 30 for women with a first-degree family history of breast cancer, BRCA gene mutation, or prior chest radiation therapy.

Digital mammography — which is what Usmanpura Imaging Centre uses — produces significantly sharper images than older analogue systems, with superior detection in women with dense breast tissue (which is more common in younger women and in the Indian population). Where mammography findings need further characterisation, we can follow up immediately with a breast ultrasound — both available under one roof.

Who should get this scan:

• All women aged 40 and above — annual or biennial screening as advised by your gynaecologist
• Women aged 30 and above with a first-degree relative (mother, sister, daughter) with breast cancer
• Women who are BRCA1 or BRCA2 gene mutation carriers — often begin screening at 25–30
• Any woman who has noticed a lump, skin change, nipple discharge, or breast asymmetry — diagnostic mammography regardless of age
• Women with a history of prior breast cancer or chest radiation therapy
• Women with dense breast tissue on prior mammogram — also need supplemental breast ultrasound